DEVELOP
Private fundings
Under the impulse of the GD¤co, Lyonbiopôle launched in 2009 new actions focused on private funding as part of its support for economic development of its SMBs members.
Indeed, to answer to the need of SMBs to be in contact with business angels, venture capital (VC) and corporate investors, two key actions have been implemented:
The Private Investment Day
Lyonbiopole organizes, in partnership with CREALYS, ECLOSION, GRAIN and OSEO, the Private Investment Day on Friday 2nd December, 2011 from 8:30 a.m. to 3:00 p.m. at the headquarters of Sanofi Pasteur in Lyon Gerland. This event aims at facilitating/reinforcing the first contacts and the interactions between companies, managers of start-up projects and investors, from all type and all kind of private funding organizations. This event will get organized around roundtables, testimonials, networking
More information about this event
SAVE THE DATE: The next edition will take place on Friday, December 2nd, 2011, and will be hosted again by Sanofi Pasteur .
The investor meetings
Organized a day, the investor meetings consist in a full day dedicated to a specific investor and organized in two different moments:
- During the day, individual meetings between member companies and private investors
- During lunch, a workshop followed by a “networking buffet” in order to facilitate the exchange between investors and SMBs.
Previous investor meetings :
June 10th, 2010: VENTECH
September 28th, 2010: VIZILLE CAPITAL INNOVATION
March 18th, 2011: SOFIMAC
May 27th, 2011 : SHAM
Upcoming "investor meetings”: Mérieux Developpement and Octalfa, Ocotber 20th, 2011.
They speak about...
« I attach great importance to our relations with China, particularly with Shanghai, which I know since 1987. I am very pleased to sign the extension of our partnership between Fudan University Cancer Hospital and Mérieux Institute. In this laboratory, Transgene and bioMérieux collaborate closely with oncologists of this great hospital. On the other hand, acquisitions of Meikang Biotech and Zenka now allows us to produce in Shanghai rapid tests and culture media essential to the diagnosis of infectious diseases. »
Alain Mérieux
bioMérieux - President